Cyber Insurance for Medical Device Makers: Patient Safety Risk

When a Software Vulnerability Becomes a Bedside Risk

A connected insulin pump, an infusion device, or a networked pacemaker programmer is not just another piece of enterprise IT equipment vulnerable to a breach, it is a piece of hardware with a direct physical connection to a patient. That distinction has reshaped how cyber insurance for medical device manufacturers gets underwritten, moving the conversation well beyond standard data breach response into territory that overlaps meaningfully with product liability and patient safety.

How does a cyberattack on a medical device actually threaten patient safety?

A compromised connected device could theoretically be manipulated or disabled remotely, creating a direct risk to the patient relying on it, not just a data confidentiality problem.

Unlike a typical IoT device where a compromise might expose data or disrupt a convenience feature, an infusion pump or a cardiac device that gets tampered with carries the possibility of a genuine physical harm outcome. This overlap between digital vulnerability and physical consequence is what Insurnest's AI Physical-Cyber Convergence Risk for Insurance was built to help underwriters evaluate, since it does not fit neatly into either a pure cyber or pure product liability framework.

Does the FDA actually require cybersecurity measures for these devices?

Yes, since March 2023 the FDA has required cybersecurity information as part of premarket submissions for many connected medical devices, following an amendment to the Federal Food, Drug, and Cosmetic Act.

This regulatory shift means manufacturers now have to document their security posture as part of getting a device approved in the first place, not as an optional add-on considered later. For underwriters, a manufacturer's premarket cybersecurity submission has become a genuinely useful piece of evidence, since it reflects a level of documented rigor that predates and often exceeds what a typical cyber insurance questionnaire would ask for on its own.

Is product liability insurance enough on its own?

No, product liability typically responds to physical defects in a device, while a cyber policy is needed to address the digital vulnerability, breach response, and related regulatory exposure.

A device that fails because of a manufacturing flaw and one that fails because of a remote software exploit may produce a similar patient outcome, but they trigger very different coverage responses, which is why medical device manufacturers increasingly need both types of coverage working together rather than assuming one covers the other's gap.

Why does device lifespan complicate this underwriting picture?

Medical devices often remain in active clinical use for a decade or longer, meaning security assumptions made at launch can become outdated long before the device is retired.

A pacemaker or infusion pump approved and deployed under security standards from several years ago may still be actively implanted or in use when new vulnerabilities are discovered, creating an ongoing patch and update challenge that most consumer electronics never have to manage at the same scale. Underwriters increasingly ask how a manufacturer handles security updates for devices already in the field, not just devices still in development.

Risk Factor	Why It Matters	Underwriting Relevance
Physical-cyber convergence	Compromise can directly affect patient safety	Distinct scoring beyond standard data breach risk
FDA premarket cybersecurity requirements	Mandatory since March 2023	Useful documentation for underwriting review
Long device lifespan	Security assumptions age faster than the device	Post-market patching and update process scrutiny
Shared firmware across product lines	One flaw can affect multiple device models	Broader recall/business interruption exposure

Can one vulnerability really affect an entire product line?

Yes, if the flaw exists in shared firmware or software components reused across multiple device models, a single vulnerability can create exposure across the manufacturer's whole portfolio at once.

This is one of the more underappreciated risks in medical device underwriting, since a manufacturer's exposure is not just about any single device's security but about how much shared code sits underneath an entire family of products. Reviewing this through a Secure Software Development Lifecycle Maturity AI Agent style assessment helps surface exactly how concentrated that shared-component risk actually is.

How does this risk connect to the hospitals using these devices?

Hospitals and manufacturers often share responsibility around network security and patching, which is why incident response for a compromised device usually involves both parties working together.

A device manufacturer's own security controls matter, but so does whether the hospital network the device connects to is properly segmented and patched, a dynamic closely related to what Cyber Insurance for Healthcare Providers: Risk Beyond HIPAA Fines covers from the hospital side of this same shared exposure.

Medical device manufacturers now sit at a genuine intersection of cyber risk and patient safety, a combination that did not exist in any meaningful way a decade ago and that most standard underwriting frameworks were never originally built to price. Manufacturers that can document secure development practices and a real post-market patching process, not just a one-time security review before launch, are the ones building the kind of underwriting file that reflects the seriousness of what is actually at stake.

Sources

• Cybersecurity | FDA, U.S. Food and Drug Administration
• Cross-Sector Cybersecurity Performance Goals, Cybersecurity and Infrastructure Security Agency